Key result
Higher hospital cardiac capability linked to ~65% lower in-hospital mortality in cardiogenic shock.
Why the study?
The association between institutional cardiac capability and outcomes in cardiogenic shock patients, especially among transferred patients and after accounting for clinical instability, remains incompletely defined.
Does treatment at higher-capability hospital tiers reduce in-hospital mortality in adult patients with cardiogenic shock?
Observational (n=1,177,180)
Yes
Does treatment at higher-capability hospital tiers reduce in-hospital mortality in adult patients with cardiogenic shock?
Higher hospital cardiac capability is independently associated with lower in-hospital mortality in patients with cardiogenic shock, effectively mitigating the mortality penalty otherwise associated with inter-hospital transfer.
No takes yet. Share an insight, caveat, or question.
Higher-capability centers were associated with lower cardiogenic shock mortality; supports regionalization but leaves open need for prospective trials.
BACKGROUND: Cardiogenic shock remains associated with high short-term mortality despite contemporary advances in care. The association between institutional cardiac capability and outcomes-particularly among transferred patients and after accounting for clinical instability-remains incompletely defined. We sought to evaluate the association between hierarchical hospital cardiac capability and in-hospital mortality using a latent measure of acute physiological severity. METHODS: Using the National Inpatient Sample (2016-2022), hospitals were classified into 5 hierarchical tiers ranging from non-percutaneous coronary intervention (tier 1) to heart transplant/durable left ventricular assist device (LVAD) centers (tier 5). Generalized structural equation modeling assessed the relationship between hospital tier and mortality. A latent Acute Severity construct-comprising cardiac arrest, acute kidney and liver injury, and mechanical ventilation-was incorporated to model the effects of clinical instability. RESULTS: Among an estimated 1 177 180 cardiogenic shock hospitalizations, most occurred at cardiac surgical and transplant/LVAD centers. Crude mortality declined stepwise from non-percutaneous coronary intervention hospitals (64.4%) to transplant/LVAD centers (36.5%). After adjustment, a higher hospital tier was independently associated with lower mortality (tier 2 odds ratio [OR], 0.43 [95% CI, 0.38-0.48]; tier 3 OR, 0.37 [95% CI, 0.32-0.43]; tier 4 OR, 0.34 [95% CI, 0.30-0.38]; tier 5 OR, 0.36 [95% CI, 0.31-0.41]). Although transfer-in status was associated with increased mortality (OR 1.36 [95% CI, 1.30-1.43]), this association was attenuated at cardiac surgical and transplant/LVAD centers, consistent with mitigation of transfer-associated risk. CONCLUSIONS: Higher hospital cardiac capability is independently associated with lower mortality among patients with cardiogenic shock. Advanced centers are associated with mitigation of transfer-associated risk, supporting regionalized hub-and-spoke systems with early referral to high-capability centers.
Sethi et al. (2026) conducted an observational in Cardiogenic Shock (n=1,177,180). Treatment at higher-capability hospital centers (Tier 5: Heart transplant/durable LV AD centers) vs. Treatment at Tier 1 non-PCI capable hospitals was evaluated on In-hospital mortality (OR 0.35, 95% CI 0.31-0.40, p=<0.001). Higher hospital cardiac capability (Tier 5) was independently associated with a lower in-hospital mortality in cardiogenic shock (OR 0.35) and mitigated transfer-associated risks compared to Tier 1 centers.
Synapse has enriched 5 related papers. Consider them for comparative context: